EMKinetics raises $500K for incontinence treatment
EMKinetics, a Santa Cruz, Calif. company that uses electric pulses as a therapy to prevent urinary incontinence, has raised a $500,000 first round of funding, according to VentureWire.
The company is using technology that it licensed from TheraNova. The electric pulses, variously called neuromodulation or neurostimulation, are also used by other companies for pain relief, hypertension and other treatments.
WS Investment, TheraNova and angel investors provided the round. EMKinetics is looking for $5-10 million in a next… Continue Reading
Life sciences briefing: Monday, Nov. 12, 2007
(UPDATED: See below.)
Featured companies: Anaptys Biosciences, Arterial Remodeling Technologies, Cambria Biosciences, CaseNet, ChemoCentryx, Ensemble Discovery, MediQuest, Piedmont Pharmaceuticals, Raven Biotechnologies, Sensys Medical, Verus Pharmaceuticals, Xanodyne Pharmaceuticals
UPDATED: Expanded items on Anaptys, Arterial Remodeling, Raven Biotech, Sensys and MediQuest. Moved ChemoCentryx and Xanodyne to a separate item.
Antibody-drug maker Raven Biotech merges with VaxGen — Raven Biotechnologies, a South San Francisco biotech developing antibody drugs, is merging with the troubled, publicly held vaccine maker VaxGen. The confusingly worded release is here.
Although… Continue Reading